DHR: Fundamental Ratio Analysis - Danaher Corporation
Danaher Corporation is a diverse company operating in various segments, showing strength in its Life Sciences division. The stock presents a balanced risk-reward profile, with opportunities for growth driven by innovative solutions across healthcare and environmental sectors.
Fundamentals Rating
The fundamentals of Danaher Corporation reveal a balanced performance across various financial metrics.
Category
Score
Visualization
Overall
3
Discounted Cash Flow
4
Return On Equity
3
Return On Assets
5
Debt To Equity
1
Price To Earnings
1
Price To Book
3
Historical Rating
Examining the historical ratings provides insight into the company's consistent performance over time.
Date
Overall Score
DCF
ROE
ROA
Debt to Equity
P/E
P/B
2025-10-14
3
4
3
5
1
1
3
2025-10-13
3
4
3
5
1
1
3
Analysts' Price Targets
Analyst price targets suggest a range of valuations reflecting varying expectations for Danaher's future performance.
High
Low
Median
Consensus
275
220
240
241.17
Analysts' Sentiments
Analyst sentiments show a predominantly positive outlook for Danaher Corporation, with notable buy recommendations.
Recommendation
Count
Visualization
Strong Buy
1
Buy
30
Hold
10
Sell
1
Strong Sell
0
Conclusion
Danaher Corporation demonstrates diversified capability, driving growth across life sciences, diagnostics, and environmental solutions. With a robust market presence and innovative product pipeline, the company is well-positioned to capitalize on emerging trends in healthcare and environmental management. However, investors should watch for challenges related to debt levels and competitive pressures. Overall, Danaher represents a compelling opportunity for growth-oriented investors with a focus on diversified industrial applications.
